DENVER, CO / ACCESS Newswire / January 20, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central ...
In their first set of experiments, the research team administered GM-CSF mRNA to the mouse endometrium via intrauterine ...
The world is having the evidence of its eyes all over again that ‘economics drives politics’ and this time around the proof ...
Objectives To describe the prevalence and characteristics of traditional, complementary and integrative medicine (TCIM) practice and product use by the population of the UK providing up-to-date data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback